MINNOVA CORP (MCI.CA) Stock Fundamental Analysis

TSX-V:MCI • CA6042501008

0.355 CAD
+0.01 (+1.43%)
Last: Feb 18, 2026, 07:00 PM
Fundamental Rating

0

Overall MCI gets a fundamental rating of 0 out of 10. We evaluated MCI against 800 industry peers in the Metals & Mining industry. MCI has a bad profitability rating. Also its financial health evaluation is rather negative. MCI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • MCI had negative earnings in the past year.
  • MCI had a negative operating cash flow in the past year.
  • MCI had negative earnings in each of the past 5 years.
  • In the past 5 years MCI reported 4 times negative operating cash flow.
MCI.CA Yearly Net Income VS EBIT VS OCF VS FCFMCI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1M -2M -3M

1.2 Ratios

  • The Return On Assets of MCI (-508.15%) is worse than 86.38% of its industry peers.
Industry RankSector Rank
ROA -508.15%
ROE N/A
ROIC N/A
ROA(3y)-328.85%
ROA(5y)-229.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MCI.CA Yearly ROA, ROE, ROICMCI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MCI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MCI.CA Yearly Profit, Operating, Gross MarginsMCI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

0

2. Health

2.1 Basic Checks

  • MCI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MCI has more shares outstanding
  • Compared to 1 year ago, MCI has a worse debt to assets ratio.
MCI.CA Yearly Shares OutstandingMCI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MCI.CA Yearly Total Debt VS Total AssetsMCI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • MCI has an Altman-Z score of -191.87. This is a bad value and indicates that MCI is not financially healthy and even has some risk of bankruptcy.
  • MCI's Altman-Z score of -191.87 is on the low side compared to the rest of the industry. MCI is outperformed by 85.63% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -191.87
ROIC/WACCN/A
WACCN/A
MCI.CA Yearly LT Debt VS Equity VS FCFMCI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

  • MCI has a Current Ratio of 0.07. This is a bad value and indicates that MCI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MCI has a Current ratio of 0.07. This is amonst the worse of the industry: MCI underperforms 83.00% of its industry peers.
  • A Quick Ratio of 0.07 indicates that MCI may have some problems paying its short term obligations.
  • MCI has a worse Quick ratio (0.07) than 82.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
MCI.CA Yearly Current Assets VS Current LiabilitesMCI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

0

3. Growth

3.1 Past

  • The earnings per share for MCI have decreased strongly by -14.50% in the last year.
EPS 1Y (TTM)-14.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-78.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MCI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MCI.CA Price Earnings VS Forward Price EarningsMCI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCI.CA Per share dataMCI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for MCI!.
Industry RankSector Rank
Dividend Yield 0%

MINNOVA CORP

TSX-V:MCI (2/18/2026, 7:00:00 PM)

0.355

+0.01 (+1.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-17
Earnings (Next)02-18
Inst Owners0.93%
Inst Owner ChangeN/A
Ins Owners13.43%
Ins Owner ChangeN/A
Market Cap43.21M
Revenue(TTM)N/A
Net Income(TTM)-1.27M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -508.15%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-328.85%
ROA(5y)-229.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -191.87
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-78.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.48%
OCF growth 3YN/A
OCF growth 5YN/A

MINNOVA CORP / MCI.CA FAQ

What is the fundamental rating for MCI stock?

ChartMill assigns a fundamental rating of 0 / 10 to MCI.CA.


Can you provide the valuation status for MINNOVA CORP?

ChartMill assigns a valuation rating of 0 / 10 to MINNOVA CORP (MCI.CA). This can be considered as Overvalued.


What is the profitability of MCI stock?

MINNOVA CORP (MCI.CA) has a profitability rating of 0 / 10.